Liver remnant hypertrophy induction - How often do we really use it in the time of computer assisted surgery?

Advances in Medical Sciences

Volumn 57, Issue 2, 2012, Pages 251-258

  Stavrou, G A ^a   Donati, M ^a   Ringe, K I ^b   Peitgen, H O ^c   Oldhafer, K J ^a  

^a ASKLEPIOS HOSPITAL BARMBEK   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF BREMEN   (Germany)

Author keywords

Computer assisted surgery; Liver hypertrophy; Liver resection; PVE; PVL; Virtual surgery planning

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; COLORECTAL METASTASIS; COMPUTER ASSISTED SURGERY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LIVER FAILURE; LIVER HYPERTROPHY; LIVER PARENCHYMA; LIVER REMNANT HYPERTROPHY; LIVER RESECTION; MALE; METASTASIS; PORTAL VEIN EMBOLIZATION; PORTAL VEIN LIGATION; PORTAL VEIN OBSTRUCTION; RETROSPECTIVE STUDY; SURVIVAL; VEIN LIGATION;

EID: 84879573424     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-012-0057-z     Document Type: Article

References (47)

1. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008 Jan;13(1):51-64. (Pubitemid 351206696)
2. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg. 1995 Jan-Feb;19(1):59-71.
3. Lupinacci R, Penna C, Nordlinger B. Hepatectomy for resectable colorectal cancer metastases-indicators of prognosis, definition of resectability, techniques and outcomes. Surg Oncol Clin N Am. 2007 Jul;16(3):493-506, vii-viii. (Pubitemid 46990949)
4. Van Cutsem E, Nordlinger B, Adam R, Köhne CH, Pozzo C, Poston G, Ychou M, Rougier P; European Colorectal Metastases Treatment Group. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer. 2006 Sep;42(14):2212-21. (Pubitemid 44307626)
5. Makuuchi M, Takayasu K, Takuma T, Yamazaki S, Hasegawa H, Nishiura S, Shimamura Y. Preoperative transcatheter embolization of the portal venous branch for patients receiving extended lobectomy due to bile duct carcinoma. J Jpn Soc Clin Surg. 1984;45:1558-64.
6. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986 Oct;10(5):803-8. (Pubitemid 17197533)
7. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001 Feb;88(2):165-75. (Pubitemid 32142701)
8. Pamecha V, Glantzounis G, Davies N, Fusai G, Sharma D, Davidson B. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases. Ann Surg Oncol. 2009 May;16(5):1202-7.
9. Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver. Ann Surg. 2011 Apr;253(4):656-65.
10. Oldhafer KJ, Högemann D, Stamm G, Raab R, Peitgen HO, Galanski M. [3-dimensional (3-D) visualization of the liver for planning extensive liver resections]. Chirurg. 1999 Mar;70(3):233-8. [Article in German]
11. Preim B, Bourquain H, Selle D, Oldhafer KJ, Peitgen H-O. Resection proposals for oncologic liver surgery based on vascular territories. In: Lemke HU, Vannier MW, Inamura K, Farman AG, Doi K, Reiber JHC, editors. CARS 2002: Computer Assisted Radiology and Surgery. Proceedings of the 16th International Congress and Exhibition; Paris, 2002 Jun 26-29; Paris. New York: Springer-Verlag; 2002. p. 353-8.
12. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. (Pubitemid 38963009)
13. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, Hayakawa N, Yamamoto H. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology. 1995 Feb;21(2):434-9.
14. Nagino M, Nimura Y, Hayakawa N. Percutaneous transhepatic portal embolization using newly devised catheters: preliminary report. World J Surg. 1 993 J ul- Aug;17(4):520-4.
15. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, Yamazaki S, Hasegawa H, Ozaki H. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990 May;107(5):521-7. (Pubitemid 20156653)
16. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, Wex C, Lobeck H, Hintze R. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999 Dec;230(6):808-18; discussion 819.
17. Neuhaus P, Thelen A. Radical surgery for right-sided klatskin tumor. HPB (Oxford). 2008;10(3):171-3. (Pubitemid 352016242)
18. Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, Sibert A, Vilgrain V, Belghiti J. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg. 2008 Feb;12(2):297-303.
19. Adam R, Bismuth H, Castaing D, Waechter F, Navarro F, Abascal A, Majno P, Engerran L. Repeat hepatectomy for colorectal liver metastases. Ann Surg. 1997 Jan;225(1):51-60; discussion 60-2.
20. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg. 2000 Dec;232(6):777-85.
21. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg. 2004 Dec;240(6):1037- 49; discussion 1049-51.
22. Sugimoto T, Yamada T, Iwata H, Sekino T, Matsumoto S, Ishida N, Manabe H, Kimura M, Takemura H. Two-stage portal vein ligation facilitates liver regeneration in rats. Eur Surg Res. 2009;42(3):181-8.
23. van Gulik TM, van den Esschert JW, de Graaf W, van Lienden KP, Busch OR, Heger M, van Delden OM, Laméris JS, Gouma DJ. Controversies in the use of portal vein embolization. Dig Surg. 2008;25(6):436-44.
24. Furrer K, Tian Y, Pfammatter T, Jochum W, El-Badry AM, Graf R, Clavien PA. Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver. Hepatology. 2008 May;47(5):1615-23. (Pubitemid 351702744)
25. Tashiro S. Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different? J Hepatobiliary Pancreat Surg. 2009;16(3):292-9.
26. Broering DC, Hillert C, Krupski G, Fischer L, Mueller L, Achilles EG, Schulte am Esch J, Rogiers X. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg. 2002 Nov-Dec;6(6):905-13; discussion 913. (Pubitemid 40433478)
27. Wilms C, Mueller L, Lenk C, Wittkugel O, Helmke K, Krupski-Berdien G, Rogiers X, Broering DC. Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg. 2008 May;247(5):825-34. (Pubitemid 351591518)
28. Maggiori L, Bretagnol F, Sibert A, Paradis V, Vilgrain V, Panis Y. Selective portal vein ligation and embolization induce different tumoral responses in the rat liver. Surgery. 2011 Apr;149(4):496-503.
29. de Graaf W, van den Esschert JW, van Lienden KP, van Gulik TM. Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol. 2009 Feb;16(2):423-30.
30. Pamecha V, Levene A, Grillo F, Woodward N, Dhillon A, Davidson BR. Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer. 2009 Feb 24;100(4):617-22.
31. Mueller L, Hillert C, Möller L, Krupski-Berdien G, Rogiers X, Broering DC. Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol. 2008 Jul;15(7):1908-17.
32. Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA, Azoulay D, Bismuth H, Castaing D, Adam R. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg. 2008 Dec;248(6):994-1005.
33. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Levi F, Bismuth H. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004 Dec;240(6):1052-61; discussion 1061-4.
34. Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg. 2006 Sep;93(9):1091-8. (Pubitemid 44343506)
35. de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM. Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg. 2011 Jun;98(6):825-34. doi: 10.1002/bjs.7456.
36. Oldhafer KJ, Donati M, Maghsoudi T, Ojdaniæ D, Stavrou GA. Integration of 3D volumetry, portal vein transection and in situ split procedure: a new surgical strategy for inoperable liver metastasis. J Gastrointest Surg. 2012 Feb;16(2):415-6.
37. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, Lemoine A, Bismuth H. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000 Apr;231(4):480-6. (Pubitemid 30185853)
38. Tsim N, Healey AJ, Frampton AE, Habib NA, Bansi DS, Wasan H, Cleator SJ, Stebbing J, Lowdell CP, Jackson JE, Tait P, Jiao LR. Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key. Ann Surg Oncol. 2011 Jul;18(7):1939-46.
39. Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, Sofocleous CT, D'Angelica M, Getrajdman GI, DeMatteo R, Kemeny NE, Fong Y. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008 Mar;247(3):451-5.
40. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Kunstlinger F, Levi F, Bismuth F. Fiveyear survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001 May;8(4):347-53. (Pubitemid 32422861)
41. Nordlinger B, Benoist S. Benefits and risks of neoadjuvant therapy for liver metastases. J Clin Oncol. 2006 Nov 1;24(31):4954-5. (Pubitemid 46631395)
42. Zorzi D, Chun YS, Madoff DC, Abdalla EK, Vauthey JN. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol. 2008 Oct;15(10):2765-72.
43. Högemann D, Stamm G, Shin H, Oldhafer KJ, Schlitt HJ, Selle D, Peitgen HO. [Individual planning of liver surgery interventions with a virtual model of the liver and its associated structures]. Radiologe. 2000 Mar;40(3):267-73. German. (Pubitemid 30187350)
44. Lang H, Radtke A, Hindennach M, Schroeder T, Bourquain H, Schenk A, Oldhafer KJ, Prause G, Peitgen HO, Broelsch CE. [Virtual hepatic surgery-computer-assisted operation planning on the 3-dimensional reconstructed liver]. Z Gastroenterol. 2007 Sep;45(9):965-70. German. (Pubitemid 47581177)
45. Lang H, Radtke A, Hindennach M, Schroeder T, Frühauf NR, Malagó M, Bourquain H, Peitgen HO, Oldhafer KJ, Broelsch CE. Impact of virtual tumor resection and computer-assisted risk analysis on operation planning and intraoperative strategy in major hepatic resection. Arch Surg. 2005 Jul;140(7):629-38; discussion 638. (Pubitemid 41123998)
46. Rau HG, Schauer R, Helmberger T, Holzknecht N, von Rückmann B, Meyer L, Buttler E, Kessler M, Zahlmann G, Schuhmann D, Schildberg FW. Impact of virtual reality imaging on hepatic liver tumor resection: calculation of risk. Langenbecks Arch Surg. 2000 Apr;385(3):162-70. (Pubitemid 30316917)
47. Oldhafer KJ, Stavrou GA, Prause G, Peitgen HO, Lueth TC, Weber S. How to operate a liver tumor you cannot see. Langenbecks Arch Surg. 2009 May;394(3):489-94.